Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose rhythmic transdermal estradiol for bone turnover in postmenopausal women
2022-003866-19Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2023
- Countries
- 1
01
Overview
Phase 4 trial of estradiol in osteoporosis (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Serum P1NP treatment-by-time interaction. Started Apr 2023; status: completed.
02
Drugs
estradiol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2022-003866-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003866-19.